Pediatric Neurology
Volume 30, Issue 4 , Pages 247-253 , April 2004

Role of mitochondrial permeability transition in fetal brain damage in rats

  • Akihito Nakai, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan
    • Corresponding Author InformationCommunications should be addressed to:Dr. Nakai; Department of Obstetrics and Gynecology; Tama Nagayama Hospital; Nippon Medical School; 1-7-1 Nagayama; Tama-City; Tokyo, 206-8512; Japan.
    • ,
  • Yukino Shibazaki, MD

      Affiliations

    • Department of Anesthesiology, Jikeikai University School of Medicine, Tokyo, Japan
    • ,
  • Yoshinari Taniuchi, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan
    • ,
  • Hidehiko Miyake, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan
    • ,
  • Atsuko Oya, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan
    • ,
  • Toshiyuki Takeshita, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan

Received 3 June 2003 ,Accepted 9 September 2003.

References 

  1. Bernardi P, Basso E, Colonna R, et al.  Perspectives on the mitochondrial permeability transition. Biochim Biophys Acta. 1998;1365:200–206
  2. Rehncrona S, Mela L, Siesjö BK. Recovery of brain mitochondrial function in the rat after complete and incomplete cerebral ischemia. Stroke. 1979;10:437–446
  3. Hillered L, Siesjö BK, Arfors K. Mitochondrial response to transient forebrain ischemia and recirculation in rat. J Cereb Blood Flow Metab. 1984;4:438–446
  4. Allen K, Almeida A, Bates T, Clark J. Changes of respiratory chain activity in mitochondrial and synaptosomal fractions isolated from the gerbil brain after graded ischaemia. J Neurochem. 1995;64:2222–2229
  5. Almeida A, Allen KL, Bates TE, Clark JB. Effect of reperfusion following cerebral ischaemia on the activity of the mitochondrial respiratory chain in the gerbil brain. J Neurochem. 1995;65:1698–1703
  6. Kuroda S, Katsura K, Hillered L, Bates TE, Siesjö BK. Delayed treatment with α-phenyl-N-tert-butyl-nitrone (PBN) atttenuates secondary mitochondrial dysfunction after transient focal ischemia in the rat. Neurobiol Dis. 1996;3:149–157
  7. Nakai A, Kuroda S, Kristian T, Siesjö BK. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction folowing transient focal cerebral ischemia in the rat. Neurobiol Dis. 1997;4:288–300
  8. Sims NR, Pulsinelli WA. Altered mitochondrial respiration in selectively vulnerable brain subregion following transient forebrain ischemia in the rat. J Neurochem. 1987;49:1367–1374
  9. Kuroda S, Siesjö BK. Reperfusion damage following focal ischemia (Pathophsiology and therapeutic windows). Clin Neurosci. 1997;4:199–212
  10. Crompton M, Ellinger H, Costi A. Inhibition by cyclosporin A of a Ca2+ dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J. 1988;255:357–360
  11. Duchen MR, McGuinness O, Brown LA, Crompton M. On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res. 1993;10:1790–1794
  12. Richter C. Pro-oxidants and mitochondrial Ca2+ (Their relationship to apoptosis and oncogenesis). FEBS. 1993;325:104–107
  13. Bernardi P, Broekemeier KM, Pfeiffer DR. Recent progress on regulation of the mitochondrial permeability transition pore (A cyclosporin-sensitive pore in the inner mitochondrial membrane). J Bioenerg Biomemb. 1994;26:509–517
  14. Gunter KK, Gunter TE. Transport of calcium by mitochondria. J Bioenerg Biomemb. 1994;26:471–485
  15. Zamzami N, Susin SA. Mitochondrial control of nuclear apoptosis. J Exp Med. 1996;183:1533–1544
  16. Hirsch T, Marzo I, Kroemer G. Role of the mitochondrial permeability transition pore in apoptosis. Biosci Rep. 1997;17:67–76
  17. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;28:1309–1312
  18. Friberg H, Connern C, Halestrap AP, Wieloch T. Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability. J Neurochem. 1999;72:2488–2497
  19. Crompton M, Andreeva L. On the involvement of a mitochondrial pore in reperfusion injury. Basic Res Cardiol. 1993;88:513–523
  20. Broekemeier KM, Dempsey ME, Pfeiffer DR. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem. 1989;264:7826–7830
  21. Halestrap AP, Davidson AM. Inhibition of Ca2+-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J. 1990;268:153–160
  22. Connern CP, Halestrap AP. Purification and N-terminal sequencing of peptidyl-prolyl cis-trans-isomerase from rat liver mitochondrial matrix reveals the existence of a distinct mitochondrial cyclophilin. Biochem J. 1992;284:381–385
  23. Tranveer A, Virji S, Totty NF, Hsuan JJ, Ward JM, Crompton M. Involvement of cyclophilin D in the activation of a mitochondrial pore by Ca2+ and oxidant stress. Eur J Biochem. 1996;238:469–471
  24. Uchino H, Elmer E, Uchino K, Siesjö BK. Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat. Acta Physiol Scand. 1995;155:469–471
  25. Butcher SP, Henshall DC, Teramura Y, Iwasaki K, Sharkey J. Neuroprotective actions of FK506 in experimental stroke (In vivo evidence against an antiexcitotoxic mechanism). J Neurosci. 1997;15:6939–6946
  26. Yoshimoto T, Siesjö BK. Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. Brain Res. 1999;839:283–291
  27. Nakai A, Asakura H, Taniuchi Y, Koshino T, Araki T, Siesjö BK. Effect of α-phenyl-N-tert-butyl nitrone (PBN) on fetal cerebral energy metabolism during intrauterine ischemia and reperfusion in rats. Pediatr Res. 2000;47:451–456
  28. Nakai A, Taniuchi Y, Asakura H, Yokota A, Koshino T, Araki T. Secondary mitochondrial dysfunction after transient intrauterine ischemia in the fetal brain. J Obstet Gynecol Res. 2000;26:383–387
  29. Nakai A, Shibazaki Y, Taniuchi Y, Koshino T, Yokoyama K. Maternal treatment with NMDA receptor antagonist (MK-801) attenuates secondary mitochondrial dysfunction after transient intrauterine ischemia in neonatal rat brain. J Anesthesia. 2001;15:217–222
  30. Azzopardi D, Wyatt JS, Cady EB, et al.  Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy. Pediatr Res. 1989;25:445–451
  31. Nioka S, Smith A, Mayevsky A, et al.  Age dependence of steady state mitochondrial oxidative metabolism in the in vivo hypoxic dog brain. Neurol Res. 1991;13:25–32
  32. Yager JY, Brucklacher RM, Vannucci RC. Cerebral energy metabolism during hypoxia-ischemia and early recovery in immature rats. Am J Physiol. 1992;262:H672–677
  33. Lorek A, Takei Y, Cady EB, et al.  Delayed (secondary) cerebral energy failure after acute hypoxia-ischemia in newborn piglet (Continuous 48-hour studies by phosphorus magnetic resonance spectroscopy). Pediatr Res. 1994;36:699–706
  34. Gilland E, Puka-Sundvall M, Hillered L, Hagberg H. Mitochondrial function and energy metabolism after hypoxia-ischemia in the immature rat brain (Involvement of NMDA-receptor). J Cereb Blood Flow Metab. 1998;18:297–304
  35. Roth SC, Edwards AD, Cady EB, et al.  Relation between cerebral oxidative metabolism following birth asphyxia, and neurodevelopmental outcome and brain growth at one year. Dev Med Child Neurol. 1992;34:285–295
  36. Tanaka M, Natori M, Ishimoto H, Miyazaki T, Kobayashi T, Nozawa S. Experimental growth retardation produced by transient period of uteroplacental ischemia in pregnant Sprague-Dawley rats. Am J Obstet Gynecol. 1994;171:1231–1234
  37. Nakai A, Shibazaki Y, Taniuchi Y, et al.  Influence of mild hypothermia on delayed mitochondrial dysfunction after transient intrauterine ischemia in the immature rat brain. Brain Res Dev Brain Res. 2001;128:1–7
  38. Folbergrova J, MacMillan V, Siesjö BK. The effect of moderate and marked hypercapnia upon the energy state and upon the cytoplasmic NADH/NAD+ ratio of the rat brain. J Neurochem. 1972;19:2497–2505
  39. Lowry O, Rosebrough N, Farr A, Randall R. Protein measurement with folin phenol reagent. J Biol Chem. 1951;193:265–275
  40. Rosenthal RE, Hamud F, Fiskum G, Varghese PJ, Sharpe S. Cerebral ischemia and reperfusion of brain mitochondrial injury by lidoflazine. J Cereb Blood Flow Metab. 1987;7:752–758
  41. Sims N, Blass J. Expression of classical mitochondrial respiratory responses in homogenates of rat forebrain. J Neurochem. 1986;47:496–505
  42. Nakai A, Taniuchi Y, Asakura H, et al.  Developmental changes in mitochondrial activity and energy metabolism in fetal and neonatal rat brain. Brain Res Dev Brain Res. 2000;121:67–72
  43. Nakai A, Taniuchi Y, Asakura H, et al.  Developmental changes in tolerance to transient intrauterine ischemia in rat cerebral mitochondria. Am J Obstet Gynecol. 2001;184:731–735
  44. Chance B, Williams G. A method for the localization of sites for oxidative phosphorylation. Nature. 1955;178:250–254
  45. Kristian T, Gertsch J, Bates TE, Siesjö BK. Characteristics of the calcium-triggered mitochondrial permeability transition in nonsynaptic brain mitochondria (Effect of cyclosporin A and ubiquinone 0). J Neurochem. 2000;74:1999–2009
  46. Kobayashi T. The role of mitochondrial permeability transition in brain ischemia. Hokkaido J Med Sci. 2000;75:243–252
  47. Auer R, Kalimo H, Olsson Y, Wieloch T. The dentate gyrus in hypoglycemia (Pathology implicating excitotoxin-mediated neuronal necrosis). Acta Neuropathol. 1985;67:279–288
  48. Friberg H, Ferrand-Drake M, Bengtsson F, Halestrap AP, Wieloch T. Cyclosporin A, but not FK506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci. 1998;18:5151–5159
  49. Folbergrova J, Zhao Q, Katsura K, Siesjö BK. N-tert-α-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia. Proc Natl Acad Sci USA. 1995;92:5057–5061
  50. Siesjö BK, Elmer E, Janelidze S, et al.  Role and mechanisms of secondary mitochondrial failure. Acta Neurochir. 1999;72(Suppl.):7–13
  51. Shibazaki Y, Nakai A, Koshino T, Yokoyama K. Effect of the immunosuppressant drug FK506 on neonatal cerebral mitochondrial function and energy metabolism after transient intrauterine ischemia in rats. Brain Res. 2001;892:351–358
  52. Ouyang Y-B, Kuroda S, Kristian T, Siesjö BK. Release of mitochondrial aspartate aminotransferase (mAST) following transient focal ischemia suggests the opening of a mitochondrial permeability transition pore. Neurosci Res Comm. 1997;20:167–173
  53. Asakura H, Nakai A, Yokota A, Sekiguchi A, Koshino T, Araki T. Continuous observation of nitric oxide production in the fetal rat brain during uteroplacental ischemia. Fetal Diagn Ther. 1999;14:354–359
  54. Packer MA, Murphy MP. Peroxynitrite formed by simultaneous nitric oxide and superoxide generation causes cyclosporin-A-sensitive mitochondrial calcium efflux and depolarisation. Eur J Biochem. 1995;234:231–239
  55. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell free extracts (Requirement for dATP and cytochrome C). Cell. 1996;86:147–157
  56. Wyllie AH, Kerr JFR, Currie AR. Cell death (The significance of apoptosis). Int Rev Cytol. 1980;68:251–306
  57. Kerr JFR, Gobe GC, Winterford CM, Harmin BV. Anatomical methods in cell death. Meth Cell Biol. 1995;46:1–27
  58. Gogvadze V. Cyclosporin A protects mitochondria in an in vitro model of hypoxia/reperfusion injury. FEBS Lett. 1993;333:334–338
  59. Begley DJ, Squires LK, Zlokovic BV, et al.  Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A. J Neurochem. 1990;55:1222–1230
  60. Shirai A, Naito M, Tatsuta T, et al.  Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein. Biochim Biophys Acta. 1994;1222:400–404
  61. Bernareggi A, Rowland M. Physiologic modeling of cyclosporin kinetics in rat and man. J Pharmacokinet Biopharm. 1991;19:21–50

PII: S0887-8994(03)00471-5

doi: 10.1016/j.pediatrneurol.2003.09.006

Pediatric Neurology
Volume 30, Issue 4 , Pages 247-253 , April 2004

Article Tools

* Image Usage & Resolution